KROS
Keros Therapeutics Inc
11.40$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 99.3 | 29.0 | 10.0 | 6.4 | – | – | |
| – | – | – | – | – | 66.1 | 77.9 | 203.3 | 286.2 | 381.0 | 9,251.4 | 68.2 | 64.9 | 33.0 | 47.8 | 13,116.8 | 12,113.8 | – | 118,302.1 | 7,940.6 | 8,330.8 | 6,088.2 | 3,222.1 | 179.5 | 1.9 | 2.3 | 2.6 | 2.3 | 6.5 | 6.4 | |
| – | – | – | – | – | 4.7 | 6.0 | 5.8 | 5.8 | 4.2 | 4.2 | 5.6 | 5.8 | 3.1 | 4.0 | 4.7 | 3.4 | 3.6 | 3.2 | 3.6 | 4.3 | 3.9 | 3.9 | 1.1 | 0.6 | 0.8 | 0.9 | 1.8 | 0.8 | 0.8 | |
| – | – | – | – | – | 51.7 | 64.5 | 167.9 | 235.2 | 289.9 | 7,046.4 | 56.8 | 53.6 | 22.3 | 35.9 | 10,330.9 | – | – | 82,391.9 | 5,754.3 | 6,444.5 | 4,594.6 | 2,409.8 | 22.4 | -1.4 | -0.6 | -0.2 | 1.1 | -1.9 | -1.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -9.3 | -3.2 | -0.6 | 2.9 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.7 | 10.3 | 7.4 | 5.2 | – | – | |
| – | – | – | – | – | -4.1% | -4.4% | -2.4% | -2.8% | -4.8% | -5.6% | -4.6% | -4.1% | -8.9% | -7.2% | -5.4% | -8.7% | -9.5% | -13.0% | -10.6% | -7.0% | -8.9% | -6.8% | -25.5% | 10.4% | 9.8% | 13.6% | 19.1% | -27.0% | -22.9% | |
| Margins | ||||||||||||||||||||||||||||||
| – | – | – | -73.5% | -110.1% | -137.8% | -183.2% | -351.5% | -410.2% | -985.8% | -19,959.0% | 46.8% | 46.1% | 93.3% | 92.7% | -1,515.0% | -1,888.0% | – | -27,812.5% | -1,082.1% | -368.4% | -103.3% | 51.8% | 81.8% | 99.7% | 99.6% | 99.6% | 99.7% | 96.5% | – | |
| – | – | – | -105.6% | -182.1% | -264.7% | -360.9% | -622.1% | -1,038.4% | -2,175.0% | -64,798.0% | -280.5% | -322.0% | -397.6% | -436.3% | -114,790.0% | -129,533.0% | – | -1,943,075.0% | -112,543.7% | -76,732.9% | -69,615.1% | -31,341.6% | -5,939.0% | -4.8% | 0.1% | 17.7% | 27.7% | -332.6% | -305.8% | |
| – | – | – | -123.4% | -210.5% | -289.5% | -374.4% | -604.8% | -987.1% | -2,085.3% | -62,480.0% | -292.3% | -333.6% | -391.5% | -407.5% | -104,679.0% | -116,297.0% | – | -1,780,837.5% | -101,319.2% | -68,505.1% | -62,012.5% | -27,890.9% | -5,277.5% | 2.0% | 8.1% | 26.1% | 35.7% | -256.6% | -250.6% | |
| – | – | – | -162.7% | -220.5% | -268.0% | -346.5% | -495.8% | -792.1% | -1,838.4% | -51,499.0% | -314.3% | -268.8% | -293.7% | -344.4% | -71,303.0% | -105,026.0% | – | -1,534,575.0% | -84,087.4% | -58,624.4% | -53,929.5% | -21,889.9% | -4,585.9% | 20.2% | 22.8% | 35.3% | 43.4% | -175.6% | -146.1% | |
| Returns | ||||||||||||||||||||||||||||||
| – | – | – | -2,492.1% | – | -20.5% | -28.6% | -17.3% | -19.9% | -23.0% | -28.6% | -24.2% | -30.0% | -37.3% | -34.0% | -37.7% | -32.8% | -38.8% | -48.2% | -46.1% | -35.3% | -39.9% | -34.1% | -32.8% | 0.6% | 2.7% | 9.2% | 28.7% | -29.8% | -31.7% | |
| – | – | – | -112.6% | -34.7% | -19.2% | -27.1% | -16.8% | -19.1% | -22.3% | -27.2% | -23.0% | -28.5% | -34.7% | -32.4% | -34.1% | -30.3% | -35.5% | -43.7% | -41.3% | -33.0% | -36.9% | -31.3% | -30.4% | 0.5% | 2.5% | 8.7% | 25.7% | -27.3% | -28.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| – | – | – | -6.6 | -54 | -144 | -133 | -265 | -255 | -237 | -221 | -229 | -228 | -215 | -239 | -279 | – | – | -287 | -330 | -441 | -405 | -529 | -558 | -718 | -688 | -691 | -285 | -279 | -255 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -22.4 | -15.5 | -7.8 | -3.1 | – | – | |
| – | – | – | 4.5% | -41.0% | 94.0% | 94.6% | 97.1% | 96.4% | 96.8% | 95.0% | 95.3% | 95.0% | 93.2% | 95.4% | 90.4% | 92.3% | 91.6% | 90.7% | 89.8% | 93.4% | 92.5% | 92.0% | 92.8% | 92.9% | 93.3% | 94.7% | 89.7% | 91.5% | 91.2% | |
| – | – | – | 0.8 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||
| – | – | – | -1.39 | -1.16 | -1.64 | -1.86 | -2.10 | -2.12 | -2.33 | -2.67 | -2.51 | -2.79 | -3.27 | -3.21 | -3.83 | -4.10 | -4.27 | -4.80 | -5.08 | -5.44 | -4.65 | -5.03 | -4.64 | 0.10 | 0.46 | 1.59 | 3.20 | -4.34 | -4.20 | |
| – | – | – | 1.13 | 0.55 | 0.57 | 0.50 | 0.35 | 0.22 | 0.11 | 0.00 | 0.86 | 0.84 | 0.84 | 0.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.09 | 5.23 | 5.73 | 6.07 | 8.97 | 1.69 | 1.68 | |
| 1.44 | – | – | 0.06 | -1.37 | 8.02 | 6.48 | 12.10 | 10.69 | 10.11 | 9.35 | 10.38 | 9.31 | 8.78 | 9.43 | 10.15 | 12.51 | 11.02 | 9.97 | 11.03 | 15.42 | 11.66 | 14.76 | 14.17 | 17.77 | 17.40 | 17.32 | 11.15 | 14.55 | 13.25 | |
| – | – | – | -1.83 | -1.21 | -1.52 | -1.72 | -1.72 | -1.71 | -2.05 | -2.20 | -2.70 | -2.25 | -2.45 | -2.71 | -2.61 | -3.70 | -3.82 | -4.14 | -4.21 | -4.66 | -4.05 | -3.95 | -4.04 | 1.06 | 1.31 | 2.14 | 3.90 | -2.97 | -2.45 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.